Lacovin

Minoxidil, the active ingredient in Lacovin, is a vasodilator presented as a topical solution for topical use. It is used to stimulate hair growth in individuals experiencing androgenetic alopecia and other forms of hair loss. GNH USA supplies Lacovin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil is a topical vasodilator indicated for conditions affecting hair growth. - Androgenetic alopecia (male pattern hair loss): promotes regrowth of scalp hair and slows further loss. - Female pattern hair loss: helps increase hair density on the scalp. - Telogen effluvium: may accelerate the return of normal hair growth after shedding episodes.

Minoxidil may cause local and systemic reactions when applied to the scalp.

Common Side Effects: - Scalp irritation or itching - Dryness or flaking of the treated skin - Redness or mild erythema - Unwanted facial hair (hypertrichosis) - Contact dermatitis - Burning sensation at the application site

Serious or Rare Side Effects: - Severe allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Rapid or irregular heartbeat - Dizziness or faintness - Swelling of hands, feet, or lower legs - Unexplained weight gain or fluid retention

Before using Lacovin, consider the following safety measures. - Avoid application on irritated, inflamed, or broken skin: may increase discomfort. - Keep product away from eyes and mucous membranes: accidental contact can cause irritation. - Discontinue use if severe scalp irritation or allergic reaction occurs: seek medical advice. - Pregnancy or breastfeeding: safety has not been established; consult a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Minoxidil can interact with other agents that affect blood pressure or skin integrity.

Major Interactions (Avoid): - Oral antihypertensive drugs (e.g., beta‑blockers, ACE inhibitors): may enhance hypotensive effects. - Concurrent use of other topical vasodilators: risk of additive blood‑pressure lowering. - Systemic vasodilators: may lead to excessive cardiovascular effects.

Moderate Interactions (Monitor Closely): - Topical irritants such as retinoids or salicylic acid: can increase scalp irritation. - Hair dyes or chemical treatments applied to the same area: may affect absorption. - Systemic medications that influence potassium channels: monitor for unexpected reactions.